Innoviva
Get Full AccessDescription
- Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva's website at www.inva.com.
-
Headquarters:1350 Bayshore Highway , Burlingame, California, United States
More -
Phone Number: +1 650-808-6000
-
Website: https://www.inva.com
-
Employees:9
-
Revenue:$1 - 10M
-
Legal Name:Innoviva
-
Innoviva's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Innoviva
-
Where are Innoviva's Headquarters?
Innoviva's Headquarters are in 1350 Bayshore Highway ,Burlingame,California,United States
-
What is Innoviva's phone number?
Innoviva's phone number is +1 650-808-6000
-
What is Innoviva's official website?
Innoviva's official website is https://www.inva.com
-
What is Innoviva's Revenue?
Innoviva's revenue is $1 - 10M
-
What is Innoviva's NAICS code?
Innoviva's NAICS code is 325412
-
How many employees are working in Innoviva
Innoviva has 9 employees
-
What is Innoviva's Industry?
Innoviva is in the industry of Financial Services
-
Who is Innoviva's CEO?
Innoviva's CEO is Pavel Raifeld

